Mainz Biomed B.V. (MYNZ) Revenue & Revenue Breakdown
Mainz Biomed B.V. Revenue Highlights
Latest Revenue (Y)
$895.48K
Latest Revenue (Q)
$214.76K
Mainz Biomed B.V. Revenue by Period
Mainz Biomed B.V. Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $895.48K | 69.00% |
2022-12-31 | $529.88K | -8.22% |
2021-12-31 | $577.35K | 16.98% |
2020-12-31 | $493.56K | 75.40% |
2019-12-31 | $281.39K | - |
Mainz Biomed B.V. Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2023-12-31 | $214.76K | 18.22% |
2023-09-30 | $181.67K | -27.02% |
2023-06-30 | $248.94K | -0.46% |
2023-03-31 | $250.10K | 29.40% |
2022-12-31 | $193.28K | 99.69% |
2022-09-30 | $96.79K | -30.49% |
2022-06-30 | $139.24K | 38.46% |
2022-03-31 | $100.56K | -37.16% |
2021-12-31 | $160.04K | 10.88% |
2021-09-30 | $144.34K | -65.41% |
2021-06-30 | $417.31K | 189.12% |
2021-03-31 | $144.34K | 16.98% |
2020-12-31 | $123.39K | - |
2020-09-30 | $123.39K | - |
2020-06-30 | $123.39K | - |
2020-03-31 | $123.39K | 75.40% |
2019-12-31 | $70.35K | - |
2019-09-30 | $70.35K | - |
2019-06-30 | $70.35K | - |
2019-03-31 | $70.35K | - |
Mainz Biomed B.V. Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
FONR | FONAR | $102.88B | $25.94M |
GTH | Genetron | $650.71M | $201.32M |
NOTV | Inotiv | $572.42M | $105.79M |
BNR | Burning Rock Biotech | $537.43M | $125.62M |
LMDX | LumiraDx | $254.48M | $21.00M |
OLK | Olink AB (publ) | $169.91M | $28.59M |
LAB | Standard BioTools | $106.34M | $44.97M |
STIM | Neuronetics | $71.35M | $16.45M |
MDXH | MDxHealth SA | $70.19M | $19.83M |
BDSX | Biodesix | $49.09M | $18.15M |
PRE | Prenetics Global | $21.74M | $6.41M |
DRIO | DarioHealth | $20.35M | $6.25M |
APDN | Applied DNA Sciences | $13.37M | $797.52K |
MYNZ | Mainz Biomed B.V. | $895.48K | $214.76K |
SERA | Sera Prognostics | $306.00K | $24.00K |
NDRA | ENDRA Life Sciences | - | - |